Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Absorica

Generic name: Isotretinoin

FDA application holder: Sun Pharm Inds Inc

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Absorica?
Absorica is a brand name of Isotretinoin, a prescription medicine. The FDA NDC Directory lists 6 Absorica products in 6 strengths and forms.
Who makes Absorica?
Sun Pharm Inds Inc holds the FDA application for Absorica (NDA021951, approved May 25, 2012).
Is there a generic or store brand of Absorica?
Yes. The FDA NDC Directory lists 51 other products with the same active ingredients, strength and form as a Absorica product, 51 of them generic. Ask your pharmacist whether one is right for you.
What do pharmacies pay for Absorica?
CMS lists a National Average Drug Acquisition Cost (NADAC) for 3 Absorica strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
Has Absorica been recalled?
FDA enforcement reports list 2 recalls of Absorica products; the newest started December 7, 2018. A recall usually concerns specific lots, not every product.

What Absorica is

Each Absorica product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Isotretinoin · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
isotretinoin 10 mg
capsule (oral)
Absorica 9 products, 7 companies DailyMed
isotretinoin 20 mg
capsule (oral)
Absorica 10 products, 7 companies DailyMed
isotretinoin 25 mg
capsule (oral)
Absorica 6 products, 6 companies DailyMed
isotretinoin 30 mg
capsule (oral)
Absorica 10 products, 7 companies DailyMed
isotretinoin 35 mg
capsule (oral)
Absorica 6 products, 6 companies DailyMed
isotretinoin 40 mg
capsule (oral)
Absorica 10 products, 7 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Isotretinoin →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Absorica products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA021951Sun Pharm Inds IncMay 25, 20126

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Absorica, by strength and form
Strength and formGeneric or brandPharmacies pay
isotretinoin 20 mg
capsule
Brand: Absorica $35.74 per capsule
Generic of the same strength and form: $1.93–$4.18 per capsule
isotretinoin 30 mg
capsule
Brand: Absorica $38.24 per capsule
Generic of the same strength and form: $2.01–$5.43 per capsule
isotretinoin 40 mg
capsule
Brand: Absorica $38.22 per capsule
Generic of the same strength and form: $2.19–$5.83 per capsule

NADAC list of November 4, 2026; these prices took effect between July 22, 2026 and October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list Absorica

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Absorica products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. December 7, 2018 · Class III · Terminated · D-1207-2019

    Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.

    Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cran — Sun Pharmaceutical Industries, Inc.

  2. June 26, 2015 · Class II · Terminated · D-1288-2015

    Incorrect/Undeclared Excipients: Product contains undeclared FD&C Yellow No. 5 in the capsule shell.

    Absorica (isotretinoin) Capsules, 25 mg, Packaged in 3 x 10 Count Blister Cards/Box, Rx Only. Manufactured for: RANBAXY LABORATORIES, INC Jacksonville, FL 32257 USA. NDC: 10631-133-31. — Ranbaxy Inc.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers